Vista Pharmaceuticals, 524711, Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

46.16
N/A
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

54.53
N/A
1.09

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-4.15
51.30
115.95

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
18.43
-1.38

PAT CAGR (%)

10 Years
5 Years
3 Years

-
18.26
-6.34

P:E (Median)

8 Years
5 Years
3 Years

P:BV (Average)

8 Years
5 Years
3 Years

1.19
1.26
1.42

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-17.49
-31.83
-25.34

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 2.42 2.56 -5.47% 1.46 2.50 -41.60% 1.52 1.80 -15.56% 3.23 3.13 3.19%
Expenses 5.42 4.07 33.17% 4.90 3.32 47.59% 2.63 2.57 2.33% 4.14 2.87 44.25%
EBITDA -3.01 -1.52 - -3.44 -0.82 - -1.11 -0.78 - -0.91 0.26 -
EBIDTM -124.36% -59.37% -235.09% -33.03% -73.14% -43.29% -28.20% 8.36%
Other Income 0.09 0.12 -25.00% 0.19 0.01 1,800.00% 0.00 0.07 -100.00% 0.24 0.10 140.00%
Interest 0.18 0.22 -18.18% 0.18 0.25 -28.00% 0.19 0.28 -32.14% 0.21 0.28 -25.00%
Depreciation 0.19 0.19 0.00% 0.20 0.18 11.11% 0.18 0.18 0.00% 0.19 0.18 5.56%
PBT -3.28 -1.81 - -3.62 -1.25 - -1.48 -1.17 - -1.06 -0.10 -
Tax -0.96 -0.48 - -1.03 -0.28 - -0.19 -0.31 - 0.43 -0.19 -
PAT -2.32 -1.32 - -2.59 -0.98 - -1.29 -0.86 - -1.49 0.09 -
PATM -95.95% -51.78% -177.02% -39.08% -84.92% -47.74% -46.25% 2.87%
EPS -0.38 -0.21 - -0.42 -0.16 - -0.21 -0.14 - -0.24 0.01 -

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 8.63 10.07 10.29 1.00 0.39 1.27 22.76 31.07 28.92 24.18 15.38 Net Sales Growth -13.61% -2.14% 929.00% 156.41% -69.29% -94.42% -26.75% 7.43% 19.60% 57.22% Cost Of Goods Sold 7.92 8.35 8.89 2.83 0.36 0.73 22.97 25.41 15.96 16.10 9.57 Gross Profit 0.71 1.73 1.40 -1.82 0.03 0.54 -0.21 5.66 12.96 8.08 5.81 GP Margin 8.26% 17.18% 13.61% -182.00% 7.69% 42.52% -0.92% 18.22% 44.81% 33.42% 37.78% Total Expenditure 17.09 14.10 13.84 5.32 1.66 3.00 27.56 29.84 23.58 21.13 12.78 Power & Fuel Cost - 0.49 0.57 0.23 0.22 0.28 0.39 0.46 0.70 0.50 0.36 % Of Sales - 4.87% 5.54% 23.00% 56.41% 22.05% 1.71% 1.48% 2.42% 2.07% 2.34% Employee Cost - 2.00 1.79 0.51 0.57 1.15 1.30 1.18 0.87 0.70 0.81 % Of Sales - 19.86% 17.40% 51.00% 146.15% 90.55% 5.71% 3.80% 3.01% 2.89% 5.27% Manufacturing Exp. - 0.54 0.48 0.15 0.07 0.14 1.46 0.39 0.93 0.43 0.81 % Of Sales - 5.36% 4.66% 15.00% 17.95% 11.02% 6.41% 1.26% 3.22% 1.78% 5.27% General & Admin Exp. - 2.20 1.45 0.53 0.30 0.66 1.10 0.82 1.10 0.62 0.65 % Of Sales - 21.85% 14.09% 53.00% 76.92% 51.97% 4.83% 2.64% 3.80% 2.56% 4.23% Selling & Distn. Exp. - 0.36 0.28 0.01 0.07 0.01 0.00 0.20 1.47 1.78 0.42 % Of Sales - 3.57% 2.72% 1.00% 17.95% 0.79% 0% 0.64% 5.08% 7.36% 2.73% Miscellaneous Exp. - 0.16 0.38 1.06 0.07 0.03 0.32 1.38 2.54 0.99 0.42 % Of Sales - 1.59% 3.69% 106.00% 17.95% 2.36% 1.41% 4.44% 8.78% 4.09% 1.04% EBITDA -8.47 -4.03 -3.55 -4.32 -1.27 -1.73 -4.80 1.23 5.34 3.05 2.60 EBITDA Margin -98.15% -40.02% -34.50% -432.00% -325.64% -136.22% -21.09% 3.96% 18.46% 12.61% 16.91% Other Income 0.52 0.44 0.33 0.40 0.17 0.20 3.75 2.95 0.40 0.06 0.02 Interest 0.76 0.97 1.24 1.34 0.90 1.55 1.54 1.67 1.57 0.88 0.77 Depreciation 0.76 0.74 0.72 0.62 0.62 0.73 1.35 1.36 1.34 1.02 1.02 PBT -9.44 -5.29 -5.18 -5.88 -2.62 -3.81 -3.94 1.15 2.83 1.22 0.84 Tax -1.75 -0.64 -0.67 -0.21 -1.73 -1.80 -0.26 0.21 0.64 -0.02 0.06 Tax Rate 18.54% 12.10% 12.93% 3.57% 66.03% 47.24% 6.60% 18.26% 22.61% -1.64% 7.14% PAT -7.69 -4.65 -4.51 -5.66 -0.89 -2.01 -3.68 0.94 2.19 1.25 0.77 PAT before Minority Interest -7.69 -4.65 -4.51 -5.66 -0.89 -2.01 -3.68 0.94 2.19 1.25 0.77 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -89.11% -46.18% -43.83% -566.00% -228.21% -158.27% -16.17% 3.03% 7.57% 5.17% 5.01% PAT Growth 0.00% - - - - - - -57.08% 75.20% 62.34% EPS -1.25 -0.75 -0.73 -0.92 -0.14 -0.33 -0.60 0.15 0.36 0.20 0.13

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 45.42 40.46 36.71 35.45 32.85 29.64 35.80 31.86 16.61 11.21 Share Capital 12.31 9.43 7.51 7.36 7.36 6.07 6.07 5.83 5.31 5.00 Total Reserves 33.10 26.22 23.04 28.09 25.49 23.57 27.25 20.46 11.29 6.21 Non-Current Liabilities -1.87 -0.28 2.60 4.02 10.51 5.18 5.89 5.66 5.49 7.93 Secured Loans 2.38 2.93 5.18 7.43 8.69 5.51 5.96 5.88 6.03 7.88 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.12 0.09 0.06 0.07 0.07 0.05 0.05 0.06 0.05 0.05 Current Liabilities 12.37 14.49 14.08 12.64 9.25 15.92 10.95 15.20 18.93 7.24 Trade Payables 5.59 7.41 7.80 5.37 5.11 5.16 5.25 9.13 12.93 6.55 Other Current Liabilities 1.74 2.06 1.14 1.91 1.88 0.56 0.25 0.31 0.45 0.09 Short Term Borrowings 5.02 5.03 4.78 5.13 2.02 9.96 5.21 5.18 5.30 0.00 Short Term Provisions 0.01 0.00 0.36 0.24 0.24 0.24 0.24 0.58 0.25 0.60 Total Liabilities 55.92 54.67 53.39 52.11 52.61 50.74 52.64 52.72 41.03 26.38 Net Block 18.70 19.32 19.74 19.33 19.93 20.66 20.52 17.67 13.46 9.96 Gross Block 27.18 27.06 26.76 25.74 25.72 25.72 24.24 20.02 14.47 18.74 Accumulated Depreciation 8.48 7.74 7.02 6.41 5.79 5.06 3.71 2.35 1.02 8.78 Non Current Assets 41.16 41.37 31.20 28.55 37.37 29.56 29.19 24.88 15.52 10.04 Capital Work in Progress 10.14 9.82 9.33 9.08 9.08 8.78 8.54 7.11 1.99 0.00 Non Current Investment 0.05 0.02 0.02 0.03 0.04 0.02 0.03 0.02 0.00 0.00 Long Term Loans & Adv. 12.16 12.11 2.01 0.00 0.10 0.10 0.10 0.08 0.07 0.08 Other Non Current Assets 0.11 0.10 0.10 0.10 8.22 0.00 0.00 0.00 0.01 0.00 Current Assets 14.76 13.30 22.19 23.56 15.24 21.19 23.45 27.84 25.50 16.34 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 8.22 6.79 7.68 9.33 9.68 9.68 11.25 10.91 8.14 2.68 Sundry Debtors 3.39 4.19 11.25 10.46 2.17 10.28 8.35 10.86 9.01 9.74 Cash & Bank 0.73 0.09 0.20 0.07 0.14 0.23 0.87 1.79 5.77 0.43 Other Current Assets 2.41 0.28 0.14 0.59 3.25 1.00 2.99 4.27 2.58 3.49 Short Term Loans & Adv. 2.00 1.95 2.92 3.11 3.15 1.00 1.18 2.38 2.50 0.02 Net Current Assets 2.39 -1.19 8.11 10.92 5.99 5.26 12.50 12.64 6.57 9.10 Total Assets 55.92 54.67 53.39 52.11 52.61 50.75 52.64 52.72 41.02 26.38

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity -6.98 -4.91 -1.71 -0.99 -6.75 0.80 3.30 -4.58 2.57 -2.50 PBT -5.29 -5.18 -5.88 -2.62 -3.69 -3.94 1.15 2.83 1.22 0.84 Adjustment 1.73 1.94 1.83 1.51 2.25 1.91 2.03 2.61 1.88 1.78 Changes in Working Capital -3.00 -1.68 1.28 0.12 -5.31 2.83 0.50 -10.03 -0.52 -4.93 Cash after chg. in Working capital -6.55 -4.91 -2.76 -0.99 -6.75 0.80 3.68 -4.58 2.59 -2.32 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.02 0.00 Tax Paid -0.43 0.00 1.05 0.00 0.00 0.00 -0.38 0.00 0.00 -0.18 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -0.44 -0.79 -1.27 -0.01 -0.30 -1.73 -5.65 -10.61 -3.61 -0.24 Net Fixed Assets -0.44 -0.79 -1.27 -0.02 -0.30 -1.72 -5.65 -10.67 2.28 -0.25 Net Investments -0.03 0.00 0.01 0.01 -0.02 0.01 -0.01 -0.02 0.00 0.00 Others 0.03 0.00 -0.01 0.00 0.02 -0.02 0.01 0.08 -5.89 0.01 Cash from Financing Activity 8.06 5.59 3.11 0.94 6.96 0.28 1.43 11.22 6.36 3.07 Net Cash Inflow / Outflow 0.64 -0.11 0.13 -0.07 -0.09 -0.64 -0.92 -3.98 5.32 0.34 Opening Cash & Equivalents 0.09 0.20 0.07 0.14 0.23 0.87 1.79 5.77 0.45 0.10 Closing Cash & Equivalent 0.73 0.09 0.20 0.07 0.14 0.23 0.87 1.79 5.77 0.43

Financial Ratios

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 7.38 7.56 8.13 9.64 8.93 9.76 10.97 9.02 6.25 4.48 ROA -8.41% -8.35% -10.73% -1.70% -3.89% -7.11% 1.78% 4.67% 3.70% 3.15% ROE -11.47% -13.63% -17.16% -2.60% -6.43% -11.68% 3.15% 10.19% 8.97% 7.15% ROCE -8.54% -8.28% -9.58% -3.75% -5.10% -5.20% 6.28% 12.42% 8.92% 9.57% Fixed Asset Turnover 0.37 0.38 0.04 0.02 0.05 0.91 1.40 1.68 1.46 0.83 Receivable days 137.33 273.88 3948.36 5842.77 1794.10 149.36 112.81 125.43 141.56 249.65 Inventory Days 271.84 256.57 3091.84 8791.54 2790.39 167.81 130.14 120.26 81.65 34.39 Payable days 284.27 312.19 849.73 5212.95 2566.27 79.41 89.81 186.95 171.33 188.84 Cash Conversion Cycle 124.89 218.25 6190.47 9421.37 2018.22 237.77 153.14 58.73 51.87 95.20 Total Debt/Equity 0.16 0.22 0.33 0.35 0.33 0.52 0.34 0.42 0.68 0.70 Interest Cover -4.47 -3.17 -3.38 -1.91 -1.46 -1.56 1.69 2.79 2.40 2.09

Top Investors:

chittajallu naga keerthi

deepthi pachipala

keshava murthy shiva shankar

rajendar balakrishna

ramaswamy reddy pedinekaluva

Annual Reports:

News Update:

Vista Pharmaceuticals enters into joint venture partnership with Pleiades Therapeutics
3rd Feb 2026, 16:51 PM

The collaboration is expected to enhance operational capabilities, expand market reach
Read More

Vista Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

BSE: 524711 | NSE: Not Listed

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

Annual Reports:

News Update:

Vista Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

BSE: 524711 | NSE: Not Listed

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Top Investors:

Annual Reports:

News Update: